GAINESVILLE, Fla. – February 14, 2011 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced its schedule of upcoming investor events.

Exactech President David Petty will present at the 2011 Canaccord Genuity 6th Annual Musculoskeletal Conference on Tuesday, February 15, 2011 in San Diego, California at 1:20 p.m. Pacific Time. The investor conference includes companies in orthopaedics, biologics, regenerative medicine, wound care, dental, ENT, imaging, robotic surgery and tissue sculpting. Exactech’s presentation to investors will also be available via audio webcast at http://www.hawkassociates.com/profile/exac.cfm.

Exactech will then host investor and financial analyst meetings at the company’s technical exhibit showcasing new product offerings and demonstrations for orthopaedic surgeons during the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in San Diego, February 16-18, 2011. Exactech will launch a number of new products, present clinical results and provide hands-on exposure to new instrumentation at its AAOS exhibit. New products include:

Knee
• A full U. S. market launch and a limited international rollout of the Optetrak Logic® PS, the next evolution of Exactech’s flagship knee system. Optetrak Logic® PS features a bone sparing Hi-Flex® design, net compression molded polyethylene, new tibial tray options and an expanded product scope, including half sizes.

• A new modular tray system for the company’s Low Profile Instrumentation (LPI®) instrumentation, which improves operating room efficiency while allowing surgeons to customize instruments available for each case. Surgeons and scientists will be available to present design rationales and share clinical results with the Optetrak® family of knee systems, including the new Optetrak CR Slope® PCL referencing system and technique.

Hip
• The addition of BIOLOX® delta ceramic femoral heads, a high-demand bearing surface that combines the next generation of ceramic head with Connexion GXL® crosslinked polyethylene, for a growing, more active patient population.

• Expansions to the Novation® Comprehensive Hip System featuring smaller cups and larger stems to enable surgeons to more closely match a patient’s anatomy.

Extremity
• The Equinoxe® Fx Plate -- the latest addition to Exactech’s fast-growing Equinoxe® Platform Shoulder System. The locking plate provides multiple configurations of blades and screws to address a myriad of classifications of proximal humerus fractures. The contoured design also allows suture placement and void filler deployment after the plate is secured. The fracture plate builds on the platform nature of the Equinoxe® shoulder system, which enables surgeons to convert from either a primary or fracture stem to a reverse shoulder without stem removal. A number of surgeons will be available to share their experience.

Spine
• New systems and instrumentation that address minimally invasive spinal surgery technology, interbody fusion and secure fixation of the thoracolumbar spine while improving surgeon speed and ease-of-use.

Biologics
• An expansion of the Optecure® product line to include 2cc and 20cc options. The 20cc is geared specifically for spinal application, offering Exactech a competitive advantage in the spine industry. Surgeons will be on hand to discuss novel techniques for application of cellular therapy for sports medicine-related injuries, using Exactech’s Accelerate® PRP Sport concentrating system.

Bone Cement
• A full market launch of the company’s pre-formed InterSpace® High Release antibiotic bone cement spacers for two stage revision hip, knee and shoulder arthroplasty.

Exactech President David Petty said, “The steady flow of new and improved products and methods from Exactech are providing surgeons with significant enhancements that enable them to deliver the best possible outcomes to their patients. We expect new product development characterized by our long development pipeline will continue to drive our company’s growth and our continuing ability to capture valuable market share.”

About Exactech
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at http://www.exac.com and http://www.hawkassociates.com.

An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.

Investor contacts
Jody Phillips
Chief Financial Officer
352-377-1140 begin_of_the_skype_highlighting              352-377-1140      end_of_the_skype_highlighting


Julie Marshall or Frank Hawkins
Hawk Associates
305-451-1888 begin_of_the_skype_highlighting              305-451-1888      end_of_the_skype_highlighting
E-mail: exactech@hawkassociates.com

PDF